ADVERTISEMENT
Quiz
RSV Vaccine Development Challenges
04/26/2023
Nine respiratory syncytial virus (RSV) prevention candidates are in phase 3 trials, including several vaccines for older adults. Researchers recently reviewed the development pipeline.